SIMILAR PATTERNS OF AMINO ACIDS FOR 6F3M_C_ADNC502_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1eqw | CU,ZN SUPEROXIDEDISMUTASE (Salmonellaenterica) |
PF00080(Sod_Cu) | 5 | HIS A 78ASP A 81LEU A 135GLY A 60HIS A 46 | ZN A 501 (-3.0A) ZN A 501 (-2.4A)NoneNone CU A 502 (-3.2A) | 1.29A | 6f3mC-1eqwA:0.0 | 6f3mC-1eqwA:18.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1eso | CU, ZN SUPEROXIDEDISMUTASE (Escherichiacoli) |
PF00080(Sod_Cu) | 5 | HIS A 78ASP A 81LEU A 135GLY A 60HIS A 46 | ZN A 149 ( 3.0A) ZN A 149 ( 2.4A)NoneNone CU A 150 ( 3.3A) | 1.34A | 6f3mC-1esoA:0.0 | 6f3mC-1esoA:17.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1foh | PHENOL HYDROXYLASE (Cutaneotrichosporoncutaneum) |
PF01494(FAD_binding_3)PF07976(Phe_hydrox_dim) | 5 | THR A 60ASP A 376HIS A 360LEU A 411GLY A 454 | None | 1.32A | 6f3mC-1fohA:1.6 | 6f3mC-1fohA:23.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1lbu | MURAMOYL-PENTAPEPTIDE CARBOXYPEPTIDASE (Streptomycesalbus) |
PF01471(PG_binding_1)PF08291(Peptidase_M15_3) | 5 | THR A 115GLU A 183LEU A 162GLY A 136HIS A 154 | NoneNoneNoneNone ZN A 214 ( 3.3A) | 1.39A | 6f3mC-1lbuA:0.0 | 6f3mC-1lbuA:19.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1o2d | ALCOHOLDEHYDROGENASE,IRON-CONTAINING (Thermotogamaritima) |
PF00465(Fe-ADH) | 5 | HIS A 270THR A 263ASP A 189HIS A 193GLY A 259 | FE A 900 ( 3.4A)None FE A 900 ( 2.5A) FE A 900 ( 3.4A)None | 1.11A | 6f3mC-1o2dA:2.5 | 6f3mC-1o2dA:21.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1qgc | PROTEIN (GH-LOOPFROM VIRUS CAPSIDPROTEIN VP1)PROTEIN (VIRUSCAPSID PROTEIN VP1)PROTEIN (VIRUSCAPSID PROTEIN VP2) (Foot-and-mouthdisease virus) |
PF00073(Rhv)no annotation | 5 | ASP 2 169HIS 1 123LEU 5 155GLY 1 132HIS 2 174 | None | 1.44A | 6f3mC-1qgc2:0.0 | 6f3mC-1qgc2:17.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1upx | HYDROXYLAMINEREDUCTASE (Desulfovibriodesulfuricans) |
PF03063(Prismane) | 5 | THR A 216ASP A 241LYS A 342HIS A 159GLY A 164 | None | 1.47A | 6f3mC-1upxA:undetectable | 6f3mC-1upxA:24.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1v8b | ADENOSYLHOMOCYSTEINASE (Plasmodiumfalciparum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | ASP A 134GLU A 200LYS A 230ASP A 234LEU A 392HIS A 398 | ADN A 502 (-3.1A)ADN A 502 (-4.0A)ADN A 502 (-3.0A)ADN A 502 (-2.8A)ADN A 502 ( 4.9A)ADN A 502 ( 3.5A) | 1.10A | 6f3mC-1v8bA:50.6 | 6f3mC-1v8bA:44.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1v8b | ADENOSYLHOMOCYSTEINASE (Plasmodiumfalciparum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 11 | HIS A 54THR A 56ASP A 134GLU A 200LYS A 230ASP A 234LEU A 389GLY A 397HIS A 398MET A 403PHE A 407 | ADN A 502 (-4.1A)ADN A 502 (-3.0A)ADN A 502 (-3.1A)ADN A 502 (-4.0A)ADN A 502 (-3.0A)ADN A 502 (-2.8A)NAD A 501 ( 3.8A)ADN A 502 ( 3.7A)ADN A 502 ( 3.5A)ADN A 502 (-3.6A)None | 0.43A | 6f3mC-1v8bA:50.6 | 6f3mC-1v8bA:44.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2aps | PROTEIN (CU,ZNSUPEROXIDEDISMUTASE) (Actinobacilluspleuropneumoniae) |
PF00080(Sod_Cu) | 5 | HIS A 103ASP A 106LEU A 154GLY A 84HIS A 62 | ZN A 400 ( 3.2A) ZN A 400 (-2.2A)NoneNone CU A 402 ( 3.4A) | 1.27A | 6f3mC-2apsA:undetectable | 6f3mC-2apsA:17.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2huo | INOSITOL OXYGENASE (Mus musculus) |
PF05153(MIOX) | 5 | ASP A 88LYS A 127ASP A 124LEU A 254HIS A 123 | INS A 303 (-3.7A)INS A 303 (-2.6A) FE A 302 ( 2.5A)None FE A 301 ( 3.2A) | 1.40A | 6f3mC-2huoA:undetectable | 6f3mC-2huoA:18.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2jss | CHIMERA OF HISTONEH2B.1 AND HISTONEH2A.ZUNCHARACTERIZEDPROTEIN YER030W (Saccharomycescerevisiae) |
PF00125(Histone)PF09649(CHZ)PF16211(Histone_H2A_C) | 5 | THR B 44GLU A 73LEU A 140GLY B 41HIS A 77 | None | 1.37A | 6f3mC-2jssB:undetectable | 6f3mC-2jssB:10.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2o96 | 26S PROTEASOMENON-ATPASEREGULATORY SUBUNIT 7 (Homo sapiens) |
PF01398(JAB) | 5 | ASP A 65ASP A 105GLY A 98HIS A 96PHE A 58 | None | 1.48A | 6f3mC-2o96A:undetectable | 6f3mC-2o96A:17.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ppq | HOMOSERINE KINASE (Agrobacteriumfabrum) |
PF01636(APH) | 5 | ASP A 204GLU A 205HIS A 117LEU A 110GLY A 107 | MG A 323 (-3.5A)NoneNoneNoneNone | 1.42A | 6f3mC-2ppqA:undetectable | 6f3mC-2ppqA:23.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2pqd | 3-PHOSPHOSHIKIMATE1-CARBOXYVINYLTRANSFERASE (Agrobacteriumsp.) |
PF00275(EPSP_synthase) | 5 | THR A 275ASP A 300GLU A 299LYS A 205ASP A 201 | None | 1.36A | 6f3mC-2pqdA:undetectable | 6f3mC-2pqdA:21.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2wpg | AMYLOSUCRASE ORALPHA AMYLASE (Xanthomonascampestris) |
PF00128(Alpha-amylase)PF11941(DUF3459) | 5 | HIS A 392GLU A 323HIS A 125LEU A 127GLY A 139 | None | 1.35A | 6f3mC-2wpgA:undetectable | 6f3mC-2wpgA:20.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2x2i | ALPHA-1,4-GLUCANLYASE ISOZYME 1 (Gracilariopsislemaneiformis) |
PF01055(Glyco_hydro_31) | 5 | THR A 774ASP A 813LEU A 882GLY A 918HIS A 812 | None | 1.36A | 6f3mC-2x2iA:undetectable | 6f3mC-2x2iA:18.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2y3a | PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE3-KINASE CATALYTICSUBUNIT BETA ISOFORM (Mus musculus) |
PF00454(PI3_PI4_kinase)PF00613(PI3Ka)PF00792(PI3K_C2)PF00794(PI3K_rbd)PF02192(PI3K_p85B) | 5 | ASP A 660HIS A 168LEU A 157GLY A 698HIS A 699 | None | 1.29A | 6f3mC-2y3aA:undetectable | 6f3mC-2y3aA:17.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2yt0 | AMYLOID BETA A4PROTEIN AND AMYLOIDBETA A4 PRECURSORPROTEIN-BINDINGFAMILY B MEMBER 2 (Mus musculus) |
PF00640(PID)PF10515(APP_amyloid) | 5 | HIS A 17LEU A 18GLY A 137MET A 80PHE A 133 | None | 1.29A | 6f3mC-2yt0A:undetectable | 6f3mC-2yt0A:16.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3b1r | RIBOKINASE, PUTATIVE (Burkholderiathailandensis) |
PF00294(PfkB) | 5 | THR A 271ASP A 300LEU A 60GLY A 262HIS A 265 | None | 1.18A | 6f3mC-3b1rA:4.9 | 6f3mC-3b1rA:22.34 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ce6 | ADENOSYLHOMOCYSTEINASE (Mycobacteriumtuberculosis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | ASP A 156LYS A 248ASP A 252LEU A 410HIS A 416 | ADN A 500 (-2.9A)ADN A 500 (-2.8A)ADN A 500 (-2.7A)ADN A 500 ( 4.8A)ADN A 500 ( 3.6A) | 1.30A | 6f3mC-3ce6A:52.2 | 6f3mC-3ce6A:48.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ce6 | ADENOSYLHOMOCYSTEINASE (Mycobacteriumtuberculosis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | HIS A 69THR A 71ASP A 156GLU A 218LYS A 248ASP A 252HIS A 363LEU A 407GLY A 415HIS A 416MET A 421PHE A 425 | ADN A 500 (-4.0A)ADN A 500 (-2.8A)ADN A 500 (-2.9A)ADN A 500 (-2.6A)ADN A 500 (-2.8A)ADN A 500 (-2.7A)ADN A 500 ( 3.7A)NAD A 550 (-4.2A)ADN A 500 ( 3.6A)ADN A 500 ( 3.6A)ADN A 500 (-3.7A)ADN A 500 (-4.8A) | 0.54A | 6f3mC-3ce6A:52.2 | 6f3mC-3ce6A:48.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ce6 | ADENOSYLHOMOCYSTEINASE (Mycobacteriumtuberculosis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 69THR A 74ASP A 156ASP A 252HIS A 363 | ADN A 500 (-4.0A)ADN A 500 (-4.5A)ADN A 500 (-2.9A)ADN A 500 (-2.7A)ADN A 500 ( 3.7A) | 1.25A | 6f3mC-3ce6A:52.2 | 6f3mC-3ce6A:48.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3cze | SUCROSE HYDROLASE (Xanthomonascitri) |
PF00128(Alpha-amylase) | 5 | HIS A 391GLU A 322HIS A 124LEU A 126GLY A 138 | TRS A6646 (-4.0A)NoneNoneNoneTRS A6646 ( 4.8A) | 1.33A | 6f3mC-3czeA:undetectable | 6f3mC-3czeA:22.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g1u | ADENOSYLHOMOCYSTEINASE (Leishmaniamajor) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 10 | HIS A 52THR A 54ASP A 130GLU A 155HIS A 300LEU A 343GLY A 351HIS A 352MET A 357PHE A 361 | ADN A 438 (-4.0A)ADN A 438 (-2.8A)ADN A 438 (-4.1A)ADN A 438 (-3.8A)ADN A 438 ( 4.0A)NAD A 439 ( 4.0A)ADN A 438 ( 3.8A)ADN A 438 ( 3.6A)ADN A 438 (-3.7A)None | 0.54A | 6f3mC-3g1uA:54.6 | 6f3mC-3g1uA:55.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g1u | ADENOSYLHOMOCYSTEINASE (Leishmaniamajor) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 52THR A 57ASP A 130HIS A 300MET A 357 | ADN A 438 (-4.0A)ADN A 438 (-4.6A)ADN A 438 (-4.1A)ADN A 438 ( 4.0A)ADN A 438 (-3.7A) | 1.38A | 6f3mC-3g1uA:54.6 | 6f3mC-3g1uA:55.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 62ASP A 139GLU A 199LYS A 229ASP A 233LEU A 388HIS A 394 | RAB A 602 (-3.8A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)NAD A 601 ( 3.6A) | 1.45A | 6f3mC-3glqA:53.8 | 6f3mC-3glqA:50.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233HIS A 344LEU A 385GLY A 393HIS A 394MET A 399PHE A 403 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.5A)NAD A 601 ( 4.1A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.41A | 6f3mC-3glqA:53.8 | 6f3mC-3glqA:50.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | HIS A 62THR A 67ASP A 139ASP A 233HIS A 344MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.5A)RAB A 602 (-3.6A) | 1.32A | 6f3mC-3glqA:53.8 | 6f3mC-3glqA:50.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 62THR A 67ASP A 139ASP A 233LEU A 388 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A) | 1.45A | 6f3mC-3glqA:53.8 | 6f3mC-3glqA:50.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3h4x | PHOSPHATIDYLINOSITOL-SPECIFICPHOSPHOLIPASE C1 (Streptomycesantibioticus) |
PF16670(PI-PLC-C1) | 5 | HIS A 216ASP A 146LEU A 220GLY A 215PHE A 134 | EOH A 353 (-3.9A)NoneNoneNoneNone | 1.41A | 6f3mC-3h4xA:undetectable | 6f3mC-3h4xA:21.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3h9u | ADENOSYLHOMOCYSTEINASE (Trypanosomabrucei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | HIS A 52ASP A 130GLU A 155LYS A 185ASP A 189LEU A 346 | ADN A 439 ( 4.7A)NoneNoneNAD A 438 ( 3.9A)NAD A 438 ( 4.4A)ADN A 439 ( 4.7A) | 1.26A | 6f3mC-3h9uA:56.8 | 6f3mC-3h9uA:56.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3h9u | ADENOSYLHOMOCYSTEINASE (Trypanosomabrucei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | HIS A 52THR A 54ASP A 130GLU A 155LYS A 185ASP A 189HIS A 300LEU A 343GLY A 351HIS A 352MET A 357PHE A 361 | ADN A 439 ( 4.7A)ADN A 439 (-2.7A)NoneNoneNAD A 438 ( 3.9A)NAD A 438 ( 4.4A)NoneNAD A 438 (-4.0A)ADN A 439 (-3.5A)ADN A 439 ( 3.3A)ADN A 439 ( 3.7A)None | 0.25A | 6f3mC-3h9uA:56.8 | 6f3mC-3h9uA:56.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3h9u | ADENOSYLHOMOCYSTEINASE (Trypanosomabrucei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 52THR A 57ASP A 130ASP A 189HIS A 300 | ADN A 439 ( 4.7A)ADN A 439 (-4.7A)NoneNAD A 438 ( 4.4A)None | 1.30A | 6f3mC-3h9uA:56.8 | 6f3mC-3h9uA:56.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3h9u | ADENOSYLHOMOCYSTEINASE (Trypanosomabrucei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 52THR A 57ASP A 130ASP A 189LEU A 346 | ADN A 439 ( 4.7A)ADN A 439 (-4.7A)NoneNAD A 438 ( 4.4A)ADN A 439 ( 4.7A) | 1.42A | 6f3mC-3h9uA:56.8 | 6f3mC-3h9uA:56.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3imk | PUTATIVE MOLYBDENUMCARRIER PROTEIN (Syntrophusaciditrophicus) |
PF12694(MoCo_carrier) | 5 | HIS A 104ASP A 106ASP A 141LEU A 84GLY A 135 | NoneNoneNoneNoneGOL A 158 (-4.1A) | 1.44A | 6f3mC-3imkA:undetectable | 6f3mC-3imkA:17.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 55ASP A 132GLU A 192LYS A 222ASP A 226LEU A 381HIS A 387 | ADN A 500 (-4.0A)ADN A 500 (-3.3A)ADN A 500 (-3.6A)ADN A 500 (-2.7A)ADN A 500 ( 2.6A)ADN A 500 ( 4.8A)ADN A 500 (-3.4A) | 1.36A | 6f3mC-3n58A:54.3 | 6f3mC-3n58A:53.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | HIS A 55THR A 57ASP A 132GLU A 192LYS A 222ASP A 226HIS A 337LEU A 378GLY A 386HIS A 387MET A 392PHE A 396 | ADN A 500 (-4.0A)ADN A 500 (-2.8A)ADN A 500 (-3.3A)ADN A 500 (-3.6A)ADN A 500 (-2.7A)ADN A 500 ( 2.6A)ADN A 500 ( 3.6A)NAD A 550 (-4.3A)ADN A 500 (-3.7A)ADN A 500 (-3.4A)ADN A 500 (-3.7A)None | 0.20A | 6f3mC-3n58A:54.3 | 6f3mC-3n58A:53.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 55THR A 60ASP A 132ASP A 226HIS A 337 | ADN A 500 (-4.0A)ADN A 500 (-4.6A)ADN A 500 (-3.3A)ADN A 500 ( 2.6A)ADN A 500 ( 3.6A) | 1.24A | 6f3mC-3n58A:54.3 | 6f3mC-3n58A:53.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 55THR A 60ASP A 132ASP A 226LEU A 381 | ADN A 500 (-4.0A)ADN A 500 (-4.6A)ADN A 500 (-3.3A)ADN A 500 ( 2.6A)ADN A 500 ( 4.8A) | 1.40A | 6f3mC-3n58A:54.3 | 6f3mC-3n58A:53.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 62ASP A 139GLU A 205LYS A 235ASP A 239LEU A 398HIS A 404 | ADE A 506 (-4.6A)NoneNoneNAD A 501 ( 4.2A)NAD A 501 ( 4.5A)ADE A 506 ( 4.7A)ADE A 506 (-3.4A) | 1.34A | 6f3mC-3oneA:51.6 | 6f3mC-3oneA:47.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | HIS A 62THR A 64ASP A 139GLU A 205LYS A 235ASP A 239HIS A 350LEU A 395GLY A 403HIS A 404MET A 409PHE A 413 | ADE A 506 (-4.6A)ADE A 506 (-2.8A)NoneNoneNAD A 501 ( 4.2A)NAD A 501 ( 4.5A)NoneNAD A 501 (-4.2A)ADE A 506 ( 3.6A)ADE A 506 (-3.4A)ADE A 506 (-3.8A)ADE A 506 (-4.9A) | 0.20A | 6f3mC-3oneA:51.6 | 6f3mC-3oneA:47.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 62THR A 67ASP A 139ASP A 239HIS A 350 | ADE A 506 (-4.6A)ADE A 506 (-4.5A)NoneNAD A 501 ( 4.5A)None | 1.25A | 6f3mC-3oneA:51.6 | 6f3mC-3oneA:47.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 62THR A 67ASP A 139ASP A 239LEU A 398 | ADE A 506 (-4.6A)ADE A 506 (-4.5A)NoneNAD A 501 ( 4.5A)ADE A 506 ( 4.7A) | 1.39A | 6f3mC-3oneA:51.6 | 6f3mC-3oneA:47.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3p54 | ENVELOPEGLYCOPROTEIN (Japaneseencephalitisvirus) |
PF00869(Flavi_glycoprot)PF02832(Flavi_glycop_C) | 5 | ASP A 42LEU A 371GLY A 145HIS A 144PHE A 1 | None | 1.26A | 6f3mC-3p54A:undetectable | 6f3mC-3p54A:21.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qvn | MANGANESE-CONTAININGSUPEROXIDE DISMUTASE (Candidaalbicans) |
PF00081(Sod_Fe_N)PF02777(Sod_Fe_C) | 5 | HIS A 80ASP A 170HIS A 174GLY A 75PHE A 136 | MN A 207 (-3.4A) MN A 207 (-2.7A) MN A 207 (-3.0A)NoneNone | 1.11A | 6f3mC-3qvnA:undetectable | 6f3mC-3qvnA:19.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3rre | PUTATIVEUNCHARACTERIZEDPROTEIN (Thermotogamaritima) |
PF01256(Carb_kinase)PF03853(YjeF_N) | 5 | THR A 171ASP A 55ASP A 5GLY A 173HIS A 198 | NoneGOL A 496 (-3.1A)GOL A 496 (-2.9A)NoneNone | 1.43A | 6f3mC-3rreA:4.8 | 6f3mC-3rreA:23.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3skv | SSFX3 (Streptomycessp. SF2575) |
PF13472(Lipase_GDSL_2) | 5 | HIS A 177ASP A 173HIS A 170LEU A 189GLY A 178 | None | 1.49A | 6f3mC-3skvA:2.1 | 6f3mC-3skvA:19.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4cw4 | BETA-KETOACYLSYNTHASE (Pseudomonasaeruginosa) |
PF00109(ketoacyl-synt)PF02801(Ketoacyl-synt_C) | 5 | HIS A 23ASP A 581ASP A 196GLY A 17PHE A 10 | None | 1.15A | 6f3mC-4cw4A:undetectable | 6f3mC-4cw4A:23.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ksi | LEUCINEAMINOPEPTIDASE 1,CHLOROPLASTIC (Solanumlycopersicum) |
PF00883(Peptidase_M17)PF02789(Peptidase_M17_N) | 5 | THR A 433ASP A 367LYS A 354ASP A 427LEU A 455 | None MG A 602 (-2.4A) MG A 601 ( 3.8A) MG A 601 ( 3.0A)SO4 A 603 (-3.7A) | 1.42A | 6f3mC-4ksiA:undetectable | 6f3mC-4ksiA:25.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 58ASP A 135GLU A 197LYS A 227ASP A 231LEU A 386HIS A 392 | ADN A 501 (-4.0A)ADN A 501 (-3.0A)ADN A 501 (-3.6A)ADN A 501 (-2.7A)ADN A 501 (-3.1A)ADN A 501 ( 4.7A)ADN A 501 (-3.5A) | 1.34A | 6f3mC-4lvcA:53.6 | 6f3mC-4lvcA:53.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | HIS A 58THR A 60ASP A 135GLU A 197LYS A 227ASP A 231HIS A 342LEU A 383GLY A 391HIS A 392MET A 397PHE A 401 | ADN A 501 (-4.0A)ADN A 501 (-2.8A)ADN A 501 (-3.0A)ADN A 501 (-3.6A)ADN A 501 (-2.7A)ADN A 501 (-3.1A)ADN A 501 ( 3.7A)NAD A 503 ( 3.9A)ADN A 501 (-3.6A)ADN A 501 (-3.5A)ADN A 501 (-3.7A)ADN A 501 (-4.8A) | 0.34A | 6f3mC-4lvcA:53.6 | 6f3mC-4lvcA:53.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 58THR A 63ASP A 135ASP A 231HIS A 342 | ADN A 501 (-4.0A)ADN A 501 (-4.5A)ADN A 501 (-3.0A)ADN A 501 (-3.1A)ADN A 501 ( 3.7A) | 1.23A | 6f3mC-4lvcA:53.6 | 6f3mC-4lvcA:53.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 58THR A 63ASP A 135ASP A 231LEU A 386 | ADN A 501 (-4.0A)ADN A 501 (-4.5A)ADN A 501 (-3.0A)ADN A 501 (-3.1A)ADN A 501 ( 4.7A) | 1.37A | 6f3mC-4lvcA:53.6 | 6f3mC-4lvcA:53.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4m0v | EXONUCLEASE SUBUNITSBCD (Escherichiacoli) |
PF00149(Metallophos)PF12320(SbcD_C) | 5 | HIS A 10ASP A 8HIS A 224GLY A 12HIS A 24 | MN A 402 (-3.3A) MN A 402 (-3.2A) MN A 402 (-4.0A)NoneNone | 1.49A | 6f3mC-4m0vA:undetectable | 6f3mC-4m0vA:20.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5utu | ADENOSYLHOMOCYSTEINASE (Cryptosporidiumparvum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | ASP A 137GLU A 211LYS A 241ASP A 245LEU A 404HIS A 410 | SAH A 502 (-3.4A)SAH A 502 (-3.8A)SAH A 502 (-2.9A)SAH A 502 (-2.8A)SAH A 502 ( 4.7A)SAH A 502 ( 3.5A) | 1.12A | 6f3mC-5utuA:49.3 | 6f3mC-5utuA:42.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5utu | ADENOSYLHOMOCYSTEINASE (Cryptosporidiumparvum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 11 | HIS A 53THR A 55ASP A 137GLU A 211LYS A 241ASP A 245LEU A 401GLY A 409HIS A 410MET A 415PHE A 419 | SAH A 502 (-4.0A)SAH A 502 (-2.7A)SAH A 502 (-3.4A)SAH A 502 (-3.8A)SAH A 502 (-2.9A)SAH A 502 (-2.8A)NAD A 501 (-4.1A)SAH A 502 ( 3.7A)SAH A 502 ( 3.5A)SAH A 502 (-3.6A)SAH A 502 (-4.8A) | 0.39A | 6f3mC-5utuA:49.3 | 6f3mC-5utuA:42.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5v96 | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE (Naegleriafowleri) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | ASP A 136GLU A 197LYS A 227ASP A 231LEU A 389 | ADN A 502 (-2.9A)ADN A 502 (-3.5A)ADN A 502 (-2.9A)ADN A 502 (-2.8A)ADN A 502 ( 4.7A) | 0.92A | 6f3mC-5v96A:52.7 | 6f3mC-5v96A:46.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5v96 | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE (Naegleriafowleri) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 11 | HIS A 59THR A 61ASP A 136GLU A 197LYS A 227ASP A 231LEU A 386GLY A 394HIS A 395MET A 400PHE A 404 | ADN A 502 ( 3.9A)ADN A 502 (-2.9A)ADN A 502 (-2.9A)ADN A 502 (-3.5A)ADN A 502 (-2.9A)ADN A 502 (-2.8A)NAD A 501 (-3.9A)ADN A 502 (-3.7A)ADN A 502 ( 3.4A)ADN A 502 (-3.8A)ADN A 502 (-4.9A) | 0.34A | 6f3mC-5v96A:52.7 | 6f3mC-5v96A:46.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | ASP A 131LYS A 186ASP A 190HIS A 353MET A 358PHE A 362 | NoneNoneNAD A 501 (-4.1A)NAD A 501 (-4.5A)9W4 A 502 (-3.6A)None | 1.01A | 6f3mC-5w4bA:46.9 | 6f3mC-5w4bA:58.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 55THR A 57ASP A 131GLU A 156LYS A 186MET A 358PHE A 362 | 9W4 A 502 (-3.7A)9W4 A 502 (-2.9A)NoneNoneNone9W4 A 502 (-3.6A)None | 0.73A | 6f3mC-5w4bA:46.9 | 6f3mC-5w4bA:58.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 55THR A 57ASP A 131LYS A 186ASP A 190MET A 358PHE A 362 | 9W4 A 502 (-3.7A)9W4 A 502 (-2.9A)NoneNoneNAD A 501 (-4.1A)9W4 A 502 (-3.6A)None | 0.81A | 6f3mC-5w4bA:46.9 | 6f3mC-5w4bA:58.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LYS A 186ASP A 190GLY A 352HIS A 353MET A 358PHE A 362 | NoneNAD A 501 (-4.1A)9W4 A 502 ( 3.9A)NAD A 501 (-4.5A)9W4 A 502 (-3.6A)None | 0.95A | 6f3mC-5w4bA:46.9 | 6f3mC-5w4bA:58.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LYS A 186ASP A 190LEU A 344GLY A 352HIS A 353MET A 358 | NoneNAD A 501 (-4.1A)NAD A 501 (-4.0A)9W4 A 502 ( 3.9A)NAD A 501 (-4.5A)9W4 A 502 (-3.6A) | 1.07A | 6f3mC-5w4bA:46.9 | 6f3mC-5w4bA:58.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | LYS A 186ASP A 190LEU A 347HIS A 353PHE A 362 | NoneNAD A 501 (-4.1A)9W4 A 502 (-4.1A)NAD A 501 (-4.5A)None | 1.29A | 6f3mC-5w4bA:46.9 | 6f3mC-5w4bA:58.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ywp | JEV E PROTEIN (Japaneseencephalitisvirus) |
no annotation | 5 | ASP A 42LEU A 371GLY A 145HIS A 144PHE A 1 | None | 1.48A | 6f3mC-5ywpA:undetectable | 6f3mC-5ywpA:10.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | HIS A 58ASP A 136LYS A 191ASP A 195LEU A 352HIS A 358 | ADN A 501 (-3.9A)ADN A 501 (-3.0A)ADN A 501 (-2.8A)ADN A 501 (-2.7A)ADN A 501 ( 4.8A)ADN A 501 ( 3.5A) | 1.44A | 6f3mC-6aphA:58.2 | 6f3mC-6aphA:56.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | HIS A 58THR A 60ASP A 136GLU A 161LYS A 191ASP A 195HIS A 306LEU A 349GLY A 357HIS A 358MET A 363PHE A 367 | ADN A 501 (-3.9A)ADN A 501 (-2.8A)ADN A 501 (-3.0A)ADN A 501 (-2.5A)ADN A 501 (-2.8A)ADN A 501 (-2.7A)ADN A 501 ( 3.7A)NAD A 500 ( 4.3A)ADN A 501 (-3.6A)ADN A 501 ( 3.5A)ADN A 501 (-3.7A)None | 0.55A | 6f3mC-6aphA:58.2 | 6f3mC-6aphA:56.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 58THR A 63ASP A 136ASP A 195HIS A 306 | ADN A 501 (-3.9A)ADN A 501 (-4.5A)ADN A 501 (-3.0A)ADN A 501 (-2.7A)ADN A 501 ( 3.7A) | 1.22A | 6f3mC-6aphA:58.2 | 6f3mC-6aphA:56.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 58THR A 63ASP A 136ASP A 195LEU A 352 | ADN A 501 (-3.9A)ADN A 501 (-4.5A)ADN A 501 (-3.0A)ADN A 501 (-2.7A)ADN A 501 ( 4.8A) | 1.39A | 6f3mC-6aphA:58.2 | 6f3mC-6aphA:56.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 7 | HIS A 56ASP A 134GLU A 159LYS A 189ASP A 193LEU A 350HIS A 356 | ADN A 501 (-3.9A)ADN A 501 (-2.9A)ADN A 501 (-3.9A)ADN A 501 (-2.9A)ADN A 501 (-2.7A)ADN A 501 ( 4.7A)ADN A 501 (-3.4A) | 1.37A | 6f3mC-6gbnA:57.5 | 6f3mC-6gbnA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 12 | HIS A 56THR A 58ASP A 134GLU A 159LYS A 189ASP A 193HIS A 304LEU A 347GLY A 355HIS A 356MET A 361PHE A 365 | ADN A 501 (-3.9A)ADN A 501 (-2.8A)ADN A 501 (-2.9A)ADN A 501 (-3.9A)ADN A 501 (-2.9A)ADN A 501 (-2.7A)ADN A 501 ( 3.6A)NAD A 502 (-3.9A)ADN A 501 (-3.8A)ADN A 501 (-3.4A)ADN A 501 (-3.6A)None | 0.37A | 6f3mC-6gbnA:57.5 | 6f3mC-6gbnA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 5 | HIS A 56THR A 61ASP A 134ASP A 193HIS A 304 | ADN A 501 (-3.9A)ADN A 501 (-4.6A)ADN A 501 (-2.9A)ADN A 501 (-2.7A)ADN A 501 ( 3.6A) | 1.22A | 6f3mC-6gbnA:57.5 | 6f3mC-6gbnA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 5 | HIS A 56THR A 61ASP A 134ASP A 193LEU A 350 | ADN A 501 (-3.9A)ADN A 501 (-4.6A)ADN A 501 (-2.9A)ADN A 501 (-2.7A)ADN A 501 ( 4.7A) | 1.40A | 6f3mC-6gbnA:57.5 | 6f3mC-6gbnA:undetectable |